3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Myelodysplastic Syndromes
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Myeloproliferative Disorders
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Graft vs Host Disease
3
Waldenstrom Macroglobulinemia
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Aplastic
2
Thrombocythemia, Essential
1
Skin Neoplasms
1
Sezary Syndrome
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdoid Tumor
1
Recurrence
1
Primary Myelofibrosis
1
Interventions
Etoposide
3
etoposide phosphate
2
Paclitaxel
2
Ifosfamide
2
Cisplatin
2
tremelimumab
1
pembrolizumab
1
durvalumab
1
cabozantinib
1
Sirolimus
1
Quality of Life
1
Proton Therapy
1
Mesna
1
Granulocyte Colony-Stimulating Factor
1
Cyclophosphamide
1
Celecoxib
1
Carboplatin
1
Bleomycin
1
Automobiles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neoplasms, Germ Cell and Embryonal
×
Sirolimus
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled